Could sleep apnea affect bone marrow in blood cancer patients?

NCT ID NCT04114084

Recruiting now Knowledge-focused Sponsor: Michael Tomasson Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at sleep apnea in people with MGUS or multiple myeloma, two plasma cell disorders. Researchers will collect bone marrow samples during routine biopsies to compare gene activity in patients with and without sleep apnea. The goal is to understand if sleep apnea influences the bone marrow environment and disease progression.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could reveal how sleep apnea affects bone marrow in MGUS and myeloma patients, potentially pointing to new ways to manage these conditions.
What could go wrong: This is an observational study, not a treatment trial. It is early-stage research that may not lead to direct clinical changes. Results depend on accurate data collection and may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

monoclonal gammopathy of uncertain significance plasma cell myeloma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE MULTIPLE MYELOMA

Contacts and locations

Locations

University of Iowa
RECRUITING

Iowa City, Iowa, 52242, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.